TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BBIO

BridgeBio Pharma Inc

Healthcare · Biotechnology

66.60$ -1.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

BridgeBio Pharma Inc (BBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 936 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BBIO
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
98 465 632 704 1,013 623 546 919 936
97 445 569 643 889 549 478 721 754
92 436 364 356 394 377 376 681 570
92 436 546 607 837 472 435 681 587
2.8 20 17 1.8 4.7 139
-69 38 17 0.0 27
0.4 1.6 5.6 20 46 15
45 29 26 24 28
153 566 156 596 1,878 1,868 1,889 2,377 3,013
8.6 33 60 96 135 121 144 154 288
8.0 5.3 4.9 3.7 4.1 4.5 17
1.9 14 8.9 8.9 12 12 11 9.6 36
55 92 476 1,704 1,708 1,727 1,721 1,852
-58 -164 408 58 -870 -1,255 -1,354 -1,468 -2,077
-61 -171 -440 -889 -1,437 -1,918 -2,561 -3,096 -3,821
92 92 105 118 144 147 163 186 197

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?